Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total Revenues	$ 18,836	$ 7,978
Operating expenses:
Cost of goods sold	7,125	1,784
Research and development	24,319	27,954
Selling, general and administrative	30,381	61,064
Total operating expenses	61,825	90,802
Loss from operations	(42,989)	(82,824)
Interest expense	(14,062)	(8,125)
Other income, net	320	14
Net loss	$ (56,731)	$ (90,935)
Net loss per common share - basic (in dollars per share)	$ (0.93)	$ (3.50)
Net loss per common share - diluted (in dollars per share)	$ (0.93)	$ (3.50)
Weighted-average shares outstanding - basic (in shares)	60,954,755	25,991,817
Weighted-average shares outstanding - diluted (in shares)	60,954,755	25,991,817
Other comprehensive loss:
Unrealized loss on investments	$ (232)	$ 0
Comprehensive loss	(56,963)	(90,935)
Product sales, net
Revenues:
Total Revenues	13,354	6,350
Collaboration revenue
Revenues:
Total Revenues	$ 5,482	$ 1,628